Navigation Links
Study shows short-term kidney failure in heart patients may not be as detrimental
Date:7/1/2010

CINCINNATINew research led by UC Health cardiologists shows that while short-term worsening kidney function is frequent among patients with heart failure, these patients also have better outcomes than those who have persistent kidney failure.

These findings, published in the July 2010 edition of the Journal of Cardiac Failure, could lead to more effective interventions and treatments for patients with heart failure that develop kidney problems or failure as well.

"Worsening renal function is a warning complication in patients with acute heart failure syndrome," says Andrew Burger, MD, UC Health cardiologist and co-investigator in the study. "Between 30 and 50 percent of patients hospitalized for acute heart failure have further worsening of renal function during hospitalization, but there is very little data available about the clinical implication of transient versus persistent worsening of renal function in this setting.

"This study is the first of its kind to look at this relationship to help physicians assess outcomes and possibly determine the most efficient way to treat heart patients who develop kidney failure at any degree."

Researchers studied 467 patients with acute heart failure syndrome and their creatinine measurements on days 2, 5, 14 and 30 of the study.

Creatinine is a product of creatine phosphate, or energy phosphate, in the muscle and brain. It is filtered out of the blood by the kidneys. If the filtering of the kidney is deficient, blood levels rise, and creatinine levels in blood and urine are used to calculate the kidney's function.

In this study, worsening renal function was defined as persistent when serum creatinine remained greater than 0.5 mg/dL (milligrams per deciliter) above baseline throughout to day 30 and transient when the elevated creatinine levels decreased to less than 0.5 mg/dL above baseline within the 30-day period.

"Worsening renal function occurred in 115 patients39 of those cases were considered transient," says Burger.

He adds that researchers saw death in 17.3 percent of patients without worsening renal function, 20.5 percent of patients with transient worsening dysfunction and 46.1 percent of patients with persistent renal dysfunction.

"The patients with no change in renal function and transient dysfunction have the same outcome, while patients with persistent renal dysfunction are more like to die," Burger says. "Chronic heart failure encompasses an important interaction between the heart and the kidneys, and renal dysfunction often accompanies heart failure.

"These findings give cardiologists some insight into the degree of renal dysfunction and its association with mortality in both stable and acute heart failure syndrome. Hopefully, these results will lead to further studies that may help in determining better interventions and outcomes for patients with acute heart failure."


'/>"/>

Contact: Katie Pence
katie.pence@uc.edu
513-558-4561
University of Cincinnati Academic Health Center
Source:Eurekalert

Related medicine news :

1. Casual Sex Doesnt Cause Emotional Damage: Study
2. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
3. Screening for Spinal Muscular Atrophy Not Cost-Effective: Study
4. New study finds possible source of beta cell destruction that leads to Type 1 diabetes
5. New Study Demonstrates Novel Use of Metabolic Imaging to Locate Sperm in Infertile Men -- Non-Invasive Imaging Procedure May Replace Invasive Techniques such as Testicula
6. Risk of stroke lower for recent Ontario immigrants: study
7. Definitive study confirms chemo benefit in postmenopausal breast cancer
8. Experimental stem cell treatment arrests acute lung injury in mice, study shows
9. Violence is part of the job say nurses as study shows only 1 in 6 incidents are reported
10. Controversial Autism Study Retracted by Medical Journal
11. Study Reveals Impact Of Health Insurance On Hispanics' Attitudes Towards Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... MA (PRWEB) , ... September 26, 2017 , ... CGL ... its first office under its new umbrella, CGL Technologies, LLC. , The new CGL ... industry veterans Remo Patitucci and Jon McCormack, both of whom have creative business development ...
(Date:9/26/2017)... Church, VA (PRWEB) , ... September 26, 2017 , ... ... and Cerulean Associates LLC **, Dec. 5-6, 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity ... investigators: “If initial findings indicate the firm’s electronic records may not be trustworthy and ...
(Date:9/26/2017)... ... September 26, 2017 , ... DETECTO has been ... 1, 2017, the new agreement allows Premier members, at their discretion, to take ... “DETECTO is pleased to renew our agreement with Premier to be able to ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Sound of My Song”: ... the creation of published author, Karmen Worden, a retired teacher with a passion for ... book is an intriguing and inspiring story on loss, living with depression, and finding ...
(Date:9/26/2017)... ... ... Saves Boobie and Ceebie”: a tool families can use to teach children about the love ... author, G.S. White, a devoted follower of Jesus Chris who is married with one son. ... not only for children but also to glorified God in everything he does.” --G.S. White ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 2017  Robert G. Szewc, M.D., is recognized by ... recognition of his contributions to the Medical field.      ... at the practice of Kidney and Hypertension Specialists, which ... hypertension solutions. He has worked in this position since ... as well as expertise in kidneys, hypertension, chronic disease ...
(Date:9/6/2017)... 2017 NeuroRx, a clinical stage biopharma company developing ... (ASIB), has been granted Fast Track status by the US ... (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company ... this sequential therapy targeting patients who are admitted to Emergency ... ...
(Date:9/5/2017)... another milestone in their continued growth and success of the company.  Xyntek has ... engagements regionally.  ... at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest office will support the ... In addition to Xyntek,s headquarters ...
Breaking Medicine Technology: